42 results on '"Ficara, Francesca"'
Search Results
2. A paradigm shift in disaster management: Incorporating a human rights-based approach to disaster risk reduction
3. Emerging Insights into Molecular Mechanisms of Inflammation in Myelodysplastic Syndromes
4. What is the difference between choosing to vaccinate for a mandatorily or recommended vaccine?
5. Clinical Implications of p53 Dysfunction in Patients with Myelodysplastic Syndromes
6. Bone Marrow Niches and Tumour Cells: Lights and Shadows of a Mutual Relationship
7. Safe therapeutic gene expression by a lentiviral vector for the gene therapy of autosomal recessive osteopetrosis
8. Hematopoietic Cells from Pluripotent Stem Cells: Hope and Promise for the Treatment of Inherited Blood Disorders
9. PBX1-directed stem cell transcriptional program drives tumor progression in myeloproliferative neoplasm
10. Micro‐RNAs : A safety net to protect hematopoietic stem cell self‐renewal
11. Exploitation of circulating CD34+ cells and non-genotoxic conditioning to overcome major limitations to treatment for autosomal recessive osteopetrosis
12. 3073 – PBX1 GENETIC ABLATION INHIBITS TUMOR GROWTH IN A MOUSE MODEL OF MYELOPROLIFERATIVE NEOPLASM
13. 3072 – MICRORNA-127-3P CONTROLS MURINE HEMATOPOIETIC STEM CELL MAINTENANCE BY LIMITING DIFFERENTIATION
14. Generation of an immunodeficient mouse model of tcirg1-deficient autosomal recessive osteopetrosis
15. Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis
16. Chromosome Transplantation: Correction of the Chronic Granulomatous Disease Defect in Mouse Induced Pluripotent Stem Cells
17. MicroRNA-127-3p controls murine hematopoietic stem cell maintenance by limiting differentiation
18. ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and anti-metastatic activity
19. Fusion between cancer cells and macrophages occurs in a murine model of spontaneous neu+ breast cancer without increasing its metastatic potential
20. Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts
21. MLL Becomes Functional through Intra-Molecular Interaction Not by Proteolytic Processing
22. Pbx1 restrains myeloid maturation while preserving lymphoid potential in hematopoietic progenitors
23. Pbx1 restrains myeloid maturation while preserving lymphoid potential in hematopoietic progenitors
24. Osteopetrosis rescue upon RANKL administration toRankl−/−mice: A new therapy for human RANKL-dependent ARO
25. Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: therapeutic implications
26. Proteolytically cleaved MLL subunits are susceptible to distinct degradation pathways
27. GSK-3 Promotes Conditional Association of CREB and Its Coactivators with MEIS1 to Facilitate HOX-Mediated Transcription and Oncogenesis
28. The miR-17-92 microRNA Polycistron Regulates MLL Leukemia Stem Cell Potential by Modulating p21 Expression
29. The Roles of MLL Holocomplex in Embryogenesis, Hematopoiesis and Tumor Suppression.
30. Pbx1 Regulates Self-Renewal of Long-Term Hematopoietic Stem Cells by Maintaining Their Quiescence
31. Pbx1 Regulates the Self-Renewal of Long-Term Hematopoietic Stem Cells by Maintaining Their Quiescence.
32. Molecular purging of multiple myeloma cells by ex-vivo culture and retroviral transduction of mobilized-blood CD34+ cells
33. Prognostic Evaluation of Myelodysplastic Syndromes (MDS): Analysis of Deaths Due to Age-Related Causes.
34. IL-3 or IL-7 Increases ex Vivo Gene Transfer Efficiency in ADA-SCID BM CD34+ Cells while Maintaining in Vivo Lymphoid Potential
35. Telomere Length Has Prognostic Impact in B-Cell Chronic Lymphocytic Leukemia (B-CLL).
36. Mobilized Blood CD34+Cells Transduced and Selected with a Clinically Applicable Protocol Reconstitute Lymphopoiesis in SCID-Hu Mice
37. Gene therapy for adenosine deaminase deficiency
38. Developmental expression of the T-box transcription factor T-bet/Tbx21 during mouse embryogenesis
39. Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning
40. Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement
41. Optimisation of retroviral supernatant production conditions for the genetic modification of human CD34+ cells
42. Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lymphohematopoietic progenitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.